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The cis-acting response element, A2RE, which is suf-
ficient for cytoplasmic mRNA trafficking in oligoden-
drocytes, binds a small group of rat brain proteins. Pre-
dominant among these is heterogeneous nuclear
ribonucleoprotein (hnRNP) A2, a trans-acting factor for
cytoplasmic trafficking of RNAs bearing A2RE-like se-
quences. We have now identified the other A2RE-bind-
ing proteins as hnRNP A1/A1B, hnRNP B1, and four iso-
forms of hnRNP A3. The rat and human hnRNP A3
cDNAs have been sequenced, revealing the existence of
alternatively spliced mRNAs. In Western blotting, 38-,
39-, 41-, and 41.5-kDa components were all recognized by
antibodies against a peptide in the glycine-rich region of
hnRNP A3, but only the 41- and 41.5-kDa bands bound
antibodies to a 15-residue N-terminal peptide encoded
by an alternatively spliced part of exon 1. The identities
of these four proteins were verified by Edman sequenc-
ing and mass spectral analysis of tryptic fragments gen-
erated from electrophoretically separated bands. Se-
quence-specific binding of bacterially expressed hnRNP
A3 to A2RE has been demonstrated by biosensor and UV
cross-linking electrophoretic mobility shift assays. Mu-
tational analysis and confocal microscopy data support
the hypothesis that the hnRNP A3 isoforms have a role
in cytoplasmic trafficking of RNA.
Establishment of asymmetry in cells requires selective local-
ization of proteins. This may be accomplished by directed pro-
tein transport, a well established pathway for plasma mem-
brane and secreted proteins, or by trafficking and subsequent
localization of mRNA. Localization of RNA has been intensively
studied in Drosophila and Xenopus oocytes (for reviews see
Refs. 1–6) and more recently in mammalian somatic cells
(7–12).
In 1982, Colman et al. (13) discovered that myelin basic
protein (MBP)1 mRNA is concentrated in the myelin membrane
fraction isolated from brain by density gradient centrifugation.
Subsequent experiments demonstrated that MBP mRNA is
translated close to myelin and the protein rapidly incorporated
into the nascent membrane (14–16) and lead to a model in
which MBP mRNA is recruited into RNA transport granules in
the perikaryon and then transported, by indirect attachment to
the microtubule-bound motor protein kinesin, to the myelin
compartment at the cell periphery (10, 17–21). The granules
are localized in the myelin compartment, and the RNA cargo is
translated, with the MBP being incorporated into the myelin
membrane. Deletion studies led to the conclusion that a small
element in the 3-untranslated region of the MBP mRNA, the
RNA transport sequence (RTS), is sufficient and necessary for
this cytoplasmic RNA transport in oligodendrocytes (17).
Cytoplasmic trafficking of RNA encoding -actin is also de-
pendent on inclusion in transport granules that are attached
to the cytoskeleton. In fibroblasts -actin mRNA transport is
microfilament-dependent (9, 22), whereas microtubules are im-
plicated in transport of this mRNA in neurons (23, 24).
trans-Acting factors have been isolated in pull-down experi-
ments with RTS-labeled magnetic particles. The predominant
RTS-binding protein from a number of rat tissues is heteroge-
neous nuclear ribonucleoprotein (hnRNP) A2 (25), a constitu-
ent of nuclear “core particles” that bind to nascent hnRNA and
participate in various aspects of RNA processing. Recent mu-
tational analyses have shown a close correlation between oli-
goribonucleotide binding to hnRNP A2 and the ability to sup-
port cytoplasmic RNA trafficking in oligodendrocytes (26).
Antisense oligonucleotide experiments have added support to
the proposition that hnRNP A2 is involved in this RTS-depend-
ent trafficking, and the RTS has consequently been renamed
the hnRNP A2 response element (A2RE). hnRNP A2 also en-
hances cap-dependent translation of mRNA containing the
A2RE (27).
Other, less abundant, rat brain proteins that are also repro-
ducibly isolated on immobilized A2RE have not previously been
identified. Direct Edman sequencing of proteins extracted from
SDS/polyacrylamide gel slices was unsuccessful, suggesting
that all are N-terminally blocked. By using Edman microse-
quencing and mass spectrometric fingerprinting of tryptic pep-
tides, Western blotting with antibodies raised against peptides
unique to individual members of the hnRNP A/B family, and
cloning and sequencing of rat and human cDNAs, we have now
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identified four of the A2RE-binding proteins as isoforms of
hnRNP A3 and a fifth component as hnRNP A1. hnRNP A3 has
been expressed in Escherichia coli, purified, and shown in
biosensor and UV cross-linking electrophoretic mobility shift
experiments to recognize A2RE directly, suggesting that
hnRNPA3 is not bound to RNA through interaction with
hnRNP A2. We have also found that hnRNPs A2 and A3 and
microinjected A2RE-containing RNA are localized in cytoplas-
mic transport granules in cultured neurons, suggesting that
hnRNP A3, like hnRNP A2, participates in the trafficking of
A2RE-containing RNA. These are the first reported experi-
ments on hnRNP A3, which has recently been identified as a
component of 40 S hnRNP complexes (28) but has otherwise
been described only at the cDNA level.
EXPERIMENTAL PROCEDURES
Primers—Primers designed against the 5 and 3 ends of frame
shift-corrected human fetal brain ribonucleoprotein (FBRNP; NCBI
GI:1710627) DNA coding sequence (nucleotides 31–1140) were pur-
chased from Invitrogen (Mt. Waverly, Australia). NcoI (forward primer)
and SacI (reverse primer) restriction sites were added to the 5 ends of
the primers to facilitate insertion of the PCR product into an expression
vector. The primers were forward (hA3F) 5-GTACCATGGAGGTA-
AAACCGCCG-3 and reverse (hA3R) 5-AGAGAGCTCAGAACCTTCT-
GCTACCATATCCAC-3 (coding sequences are underlined, and restric-
tion sites are in italics).
RNA Extraction and RT-PCR—21-day-old Wistar rat brain was snap
frozen. Human cerebellar tissue was from a 65-year-old female who
died of heart failure. Total RNA was isolated from 100 mg of tissue
using TRIzol reagent (Invitrogen). The dried RNA-containing pellet was
resuspended in 20 l of diethyl pyrocarbonate-treated water. RNA
purity and concentration were determined spectrophotometrically and
by electrophoresis on 2% agarose gels. RNA-dependent DNA synthesis
was performed using avian myeloblastosis virus reverse transcriptase
(AMV-RT; Promega, Annandale, Australia, for rat RNA) or SuperScript
II (Invitrogen, for human RNA). 2 g of RNA was used in each RT
reaction and primed with oligo(dT)15. Subsequent PCR reactions were
performed using the proofreading enzymes platinum Taq high fidelity
DNA polymerase (Invitrogen, for rat) and ELongase (Invitrogen, for
human) with 40 pmol of each primer in each 50-l reaction.
3-RACE was performed using an internal gene-specific primer for
reverse transcription. Terminal transferase (Invitrogen) was used for
homopolymeric 3 C-tailing of the first DNA strand. Nested PCR was
performed with RACE anchor and adapter primers (5 AP and AUAP;
Invitrogen). A modified oligo(dT) (3 AP; Invitrogen) and internal prim-
ers were used for the RT step in 3-RACE.
DNA Sequencing—Purified RT-PCR products were ligated into
pGemT-Easy (Promega) and electroporated into E. coli DH5 cells.
Cells bearing plasmids containing an appropriately sized insert were
grown overnight, the plasmids were isolated, and the inserts were
amplified using M13 universal primers and hA3F and hA3R for se-
quencing in both forward and reverse directions with partial overlap.
DNA from three individual clones was sequenced. The sequences were
analyzed using CLUSTAL W version 1.8 (29) to generate consensus
sequence and protein alignment, and the programs at ExPASy (/au.
expasy.org/) were used for conceptual translation of the DNA sequences
(30).
Antibodies—Antibodies were raised against peptides unique to each
of the human hnRNPs A1, A2/B1, B1, and A3: SKSESPKEPEQLC-NH2
(A1), GGNFGFGDSR GGC-NH2 (A2/B1), VKPPPGRPQPDSGRRC-NH2
(A3(N)), GYDGYNEGGNFC-NH2 (A3(C)), and KTLETVPLERKKRC-
NH2 (B1). These peptides were synthesized with C-terminal amide
groups (Mimetopes, Melbourne, Australia) and conjugated to diptheria
toxoid before injection into rabbits. The purified antibodies were iso-
lated from antisera by adsorption onto the corresponding immobilized
antigen.
Protein Sequencing and Mass Fingerprinting—Attempts at direct
Edman sequencing of the A2RE-binding proteins were unsuccessful,
suggesting that they were N-terminally blocked. Peptides were there-
fore generated by excision of bands from SDS/polyacrylamide gels and
in-gel digestion with 1.5 times the gel volume of 0.02 mg/ml trypsin
(Promega) in 40 mM ammonium bicarbonate, 10% (v/v) acetonitrile, pH
8.1 (31). The resultant peptides were purified by reverse-phase HPLC
on a microbore C18 column and running a gradient of 10–40% aceto-
nitrile over 60 min in 1% trifluoroacetic acid at 30 l/min and sequenced
on a Procise cLC sequencer (Applied Biosystems, Foster City, CA). Mass
spectral analysis was performed on an ABI QSTAR Pulsar i spectrom-
eter (Applied Biosystems) with an electrospray ion source interfaced to
a microbore HPLC. The peptides were separated on a C3 reverse-phase
column, the output of which was split between the HPLC detector and
the mass spectrometer. The proteins were identified by comparison of
the observed tryptic peptide masses with those predicted from the gene
sequences. For each of the hnRNP A3 isoforms, fragments with masses
within  0.2 Da of the theoretical value covering at least 33% of the
primary sequence were found.
Cloning, Expression, and Isolation of hnRNP A3—Full-length rat
hnRNP A3 transcript was amplified and ligated into pGemT. The se-
quence was verified by sequencing before ligation in-frame into
pET30a (Novagen, Madison, WI), which had been mutated to gener-
ate a second thrombin cleavage site in place of an enterokinase site
between the hexahistidine tag and hnRNP A3. This vector was used to
transform E. coli BL21(DE3) cells that were grown to an A600 of 0.6
before induction with isopropyl-1-thio--D-galactopyranoside. The cell
lysates were centrifuged, and the supernatant was passed through a
metal ion affinity column (Talon IMAC resin, CLONTECH, Palo Alto,
CA) equilibrated with 50 mM NaH2PO4, 700 mM NaCl, 5 mM imidazole,
1 mM phenylmethylsulfonyl fluoride, pH 7, or 20 mM Tris, 100 mM NaCl,
and 6 M guanidinium hydrochloride, pH 7. The hexahistidine fusion
protein was released from the resin by increasing the column buffer
imidazole concentration to 200 mM and purified by reverse-phase
HPLC. Two proteins with the tag removed and an additional Ser-Gly at
the N terminus were generated by cleavage with thrombin; they were
identified by electrospray/time-of-flight mass spectrometry performed
on an Applied Biosystems QSTAR Pulsar i.
Biosensor Measurements—An IAsys resonant mirror biosensor (Af-
finity Sensors, Cambridge, UK) was used to determine the equilibrium
affinities for the interactions of hnRNP A3 with A2RE, with NS1
(CAAGCACCGAACCCGCAACUG) being used as a control to distin-
guish specific binding from nonspecific binding. Recombinant hnRNP
A3 was covalently attached to the carboxymethyldextran-coated sens-
ing surface of a biosensor cuvette using a standard procedure (32). After
washing the biosensor cuvette with phosphate-buffered saline (PBS)
containing 0.1% Tween 20, hnRNP A3 was added to the cuvette, and the
equilibrium response was recorded (20 min). Unbound protein was
removed by washing with PBS containing 0.05% Tween 20. Binding of
oligonucleotides was monitored at 0.4-s intervals at 25 °C until equilib-
rium had been attained (15 min). The cuvette was washed with 5 mM
NaOH to remove the oligonucleotide and with PBS containing 0.05%
Tween 20 to restore the base line between experiments.
UV Cross-linking Electrophoretic Mobility Shift Assays—Recombi-
nant proteins were obtained as described above. Oligoribonucleotide 32P
end-labeled with T4 polynucleotide kinase (New England Biolabs, Bev-
erly, MA) and protein were mixed in binding buffer (10 mM Tris-HCl,
pH 7.5, containing 1 mM EDTA, 4% (w/v) glycerol, 0.1% (w/v) Triton
X-100, and 1 mM dithiothreitol) and incubated for 20–30 min on ice. The
reaction mixtures were then irradiated with 250 mJ of 254-nm light in
a Bio-Rad GS Genelinker UV chamber. The samples were run on 15 
15-cm SDS/12% or 15% polyacrylamide gels.
Affinity Isolation on Magnetic Particles—A2RE-binding rat brain
proteins were isolated using affinity isolation on superparamagnetic
particles bearing immobilized A2RE or NS1, as described previously
(25). Proteins bound to the particles were eluted by heating for 10 min
at 65 °C in 0.1% SDS, 1 mM dithiothreitol, or 30% (v/v) acetonitrile in
0.1% trifluoroacetic acid and analyzed on SDS/polyacrylamide gels or
used for mass spectrometry.
Cell Culture—Hippocampus dissected from embryonic day 18 Wistar
rats was digested with trypsin in Hanks’ balanced salt solution, washed
twice in Hanks’ balanced salt solution, placed in Dulbecco’s modified
Eagle’s medium supplemented with 10% (v/v) fetal calf serum, and
mechanically dissociated by trituration. The cells were plated at 600
cells/mm2 on poly(L-lysine)-coated glass-bottomed microwells (MatTek,
Ashland, MA). After 2 h of incubation to allow cell attachment, medium
containing Neurobasal, N2 supplements (1:100 dilution), B27 supple-
ments (1:50 dilution), and 5% (v/v) gentamicin was added, and the cells
were incubated at 37 °C in 95% air, 5% CO2. The medium was replaced
every other day. All reagents were from Invitrogen except where noted
otherwise.
Confocal Laser Scanning Microscopy—Cultured rat brain neurons
were washed in PBS then fixed for 20 min in 3.7% paraformaldehyde
(Sigma) in PBS. After further washing with PBS, the cells were perme-
abilized by incubation for 2 min in 0.1% Nonidet P-40 (Sigma) diluted in
the same buffer, washed, and then incubated in 5% goat serum in PBS
for 10 min. For visualization of hnRNPs A2 and A3, the cells were
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incubated for 30 min at room temperature in the primary antibody
(rabbit antibody against hnRNP A3 and mouse antibody to hnRNP A2),
washed extensively, blocked with 5% goat serum in PBS for 10 min,
incubated in secondary antibody (fluorescein isothiocyanate-conjugated
goat antimouse IgG and Alexa-598-conjugated goat anti-rabbit; Jackson
ImmunoResearch Laboratories, West Grove, PA) for 30 min, and
washed with PBS. Finally, 70% glycerol containing an anti-fading agent
(Dabco) was added to the cells before they were imaged on either Zeiss
FIG. 1. A2RE-binding proteins. Rat brain proteins were added, in
the presence of heparin, to A2RE immobilized on magnetic particles. A,
the bound proteins were eluted with 1% SDS, separated on an SDS/
polyacrylamide gel, and stained with Coomassie Blue. The 36-kDa
hnRNP A2 (arrow) was identified earlier (25), and hnRNP A1 is barely
visible below this band. The other four bands, which are the focus of this
study, are indicated by arrowheads with their apparent molecular
masses. B, Western blots of the A2RE-binding proteins. The proteins
separated on an SDS/12% polyacrylamide gel were electrophoretically
transferred onto nitrocellulose, and the strips were incubated in rabbit
primary antibodies raised against peptides of hnRNPs A1, A2/B1, B1,
and A3 (N-terminal peptide). The proteins were visualized using an
anti-rabbit IgG alkaline phosphatase-conjugated secondary antibody.
The positions of molecular mass standards are marked on the left. The
two hnRNP A3 bands recognized by the hnRNP A3 antibody, the 41-
and 41.5-kDa proteins in A, are not resolved on this short gel.
FIG. 2. hnRNP A3 amino acid sequences. The human hnRNP A3 sequence deduced from the cDNA sequence determined in the present work
and those of human hnRNPs A1 and A2. The rat hnRNP A3 differs from the human protein only by insertion in the latter of one additional Gly
residue in the Gly-rich region (arrowhead above the hnRNP A3 sequence). Residues in hnRNPs A1 and A2 are identified only where they differ
from the hnRNP A3 sequence. The residues conserved between hnRNPs A1 and A3 but not A2 and A3 are boxed, and those conserved between
hnRNPs A2 and A3 but not A1 and A3 are shaded. Gaps in the sequences are indicated with dashes. The minimal M9 nuclear import/export
sequence of A1 (50) and the equivalent segments of hnRNPs A2 and A3 are underlined in the C-terminal Gly-rich region. Exon 1 residues deleted
in the shorter isoform of hnRNP A3 are in bold, and the sequence within this segment used to generate the N-terminal hnRNP A3 antibody is
underlined. The arrow marks the point at which recombinant hnRNP A3 is cleaved by thrombin.
FIG. 3. Antibodies to hnRNP A3 recognize the A2RE-binding
proteins. A2RE-binding rat brain proteins from a magnetic particle
pull-down experiment were separated on an SDS/polyacrylamide gel
and electroblotted onto polyvinylidene difluoride membrane. Strips of
the electroblot were incubated with antibodies to hnRNP A2 (A2), to the
N-terminal alternatively spliced segment (A3(N)), and to the peptide
from the Gly-rich region (A3(C)). The proteins were visualized using an
anti-rabbit IgG alkaline phosphatase-conjugated secondary antibody
and development with nitroblue tetrazolium chloride/5-bromo-4-chloro-
3-indolyl phosphate, p-toluidine salt one-step solution (Pierce). The
positions of marker proteins are shown at left, and the hnRNP A3 bands
are indicated by arrowheads.
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LSM 410 or Bio-Rad MRC 800 laser scanning confocal microscopes
equipped with 63 (1.4 NA) and 60 (1.4 NA) lenses.
RNA Microinjection and Visualization—After 7–14 days in culture,
differentiated hippocampal neurons were microinjected with RNA la-
beled with Alexa-488-UTP (Molecular Probes, Eugene, OR) and con-
taining or lacking the A2RE11 (GCCAAGGAGCC) sequence inserted in
the 3-untranslated region between the green fluorescent protein open
reading frame and the segment encoding the poly(A) (26). The cells were
injected using a Compic Inject (Cellbiology Trading, Hamburg, Ger-
many) micromanipulator attached to a Zeiss Axiophot inverted micro-
scope. After injection, the cells were incubated at 37 °C for 30 min to
allow transport to occur. To visualize neurites, the cells were incubated
for 30 min in mouse anti-MAP2 (Sigma), washed, and incubated for 30
min in Texas Red-conjugated goat anti-mouse IgG (Sigma).
RESULTS
Western Blotting of A2RE-binding Proteins—Previous exper-
iments (25, 26) showed that immobilized A2RE binds at least
six polypeptides from rat brain in an RNA sequence-selective
manner (Fig. 1A). The most abundant of these proteins was
shown by Edman sequencing of tryptic peptides to be hnRNP
A2, but the other polypeptides were less abundant and ap-
peared to be N-terminally blocked. Edman protein sequencing
of peptides generated from the 38- and 39-kDa bands had
indicated that they were closely related to hnRNP A2 but were
not alternatively spliced forms of this 36-kDa protein. The
peptide sequences matched those deduced from the cDNA se-
quences of human hnRNP A3 (identified as FBRNP, as cor-
rected in the Swiss Protein Database, accession number
P51991) but were insufficient in number and length to un-
equivocally identify the protein.
We have now used immunoblotting to identify the other rat
brain A2RE-binding proteins that were eluted from magnetic
particles, separated on SDS/polyacrylamide gels, and trans-
ferred to nitrocellulose for immunodetection with polyclonal
antibodies raised against peptide antigens. The peptide anti-
gens were selected using published amino acid sequences for
the human hnRNP A1, A2, and B1 proteins, and for A3 a
peptide was deduced from our DNA sequence (see below). The
proteins detected (Fig. 1B) were hnRNPs A1, A1B (above A1 on
the A1 track, 40 kDa), A2, B1 (just above A2 on the A2 track,
and separately on the B1 track; the topmost band in the A2
track is unidentified), and A3. As shown below, the antibody to
hnRNP A3 detects two proteins, but they are not resolved on
the short gel used in this experiment. The predominant A2RE-
binding proteins are thus the previously identified hnRNP A2
and hnRNP A3. As judged by the staining on polyacrylamide
gels, hnRNPs A1, A1B, and B1 are minor components.
DNA Sequencing—As a basis for further studies we deter-
mined the cDNA sequences of rat and human brain hnRNP A3,
initially using for both RT-PCR with primers based on the 5
and 3 coding sequences of FBRNP to amplify hnRNP A3-like
mRNA. The high degree of amino acid sequence conservation
between humans and rodents observed for other hnRNPs sug-
gested that these primers would be satisfactory for the latter, a
proposition subsequently verified by direct sequencing of the
rat DNA in these regions (see below).
Two distinct sequences were amplified from multiple clones
containing cDNA reverse-transcribed from human brain RNA.
One matched and extended the partial murine clone (EMBL
accession number Y16641), a truncated expressed sequence tag
described as encoding a novel gene product, mBx-3 (28) (Fig. 2).
The second differed from that deduced for the human FBRNP
(33) only by a substitution of the dipeptide Met93-Arg94 in our
sequence for Ile-Gly at the C-terminal end of the second RNA
recognition motif of FBRNP. These two cDNAs had 96.5%
identity at the nucleotide level and 94.2% (357 of 379 residues)
at the amino acid level, with the nucleotide differences between
these human sequences spread throughout the DNA, suggest-
ing that the two proteins arise from distinct genes, but subse-
quent searching of the human genome data bases suggested
that the second of these cDNAs (corresponding to FBRNP)
resulted from transcription of a pseudogene.
The first human cDNA sequence differed from the single rat
sequence obtained from multiple clones in 55 nucleotide sub-
stitutions spread throughout the sequence and by the presence
of a TGG insert in the latter, but these differences result only
in insertion of a single additional glycine residue near the C
terminus of the rat protein, suggesting that these proteins are
orthologous. No murine cDNA corresponding to FBRNP was
detected by multiple approaches including 3- and 5-RACE
and direct RT-PCR using total rat brain RNA with an oligo(dT)
primer, again suggesting that it represents a pseudogene. How-
ever, 5-RACE did result in the identification of a truncated
form of rat DNA, which had a similar but longer 5-untrans-
lated region and a 66-nucleotide deletion near the 5 end of the
coding region (Fig. 2). This corresponds to a mass change of
2566 Da in the protein. The 3- and 5-RACE experiments also
confirmed that the human and rat sequences are identical in
the regions corresponding to the primers used in the initial
amplification of the rat DNA. The sequence of the full and
truncated cDNAs are closely related to those reported for A3-
like proteins from Xenopus, A3a and A3b (34).
Protein Features Deduced from DNA Sequence—hnRNP A1
possesses a transportin-binding nuclear localization signal
(M9) that is thought to be important for shuttling between the
nucleus and cytoplasm (35–37). The minimal 15-residue se-
quence is underlined in Fig. 2 (38). A similar sequence is
present in hnRNP A3; this suggests that hnRNP A3, like
hnRNPs A1 and A2 (39), may shuttle in and out of the nucleus.
Comparison of the amino acid sequences of the human
hnRNPs A1, A2, and A3 reveals a close relationship between
them. Overall, the hnRNP A3 amino acid sequence matches
hnRNP A1 more closely than it matches hnRNP A2/B1. Within
the tandem RNA recognition motif region there are many,
mostly conservative, substitutions in hnRNP A2 where the
other two proteins are identical and relatively few residues
where hnRNP A2 but not hnRNP A1 matches the hnRNP A3
sequence (Fig. 2). In the C-terminal glycine-rich region, this
trend is reversed, suggesting that the hnRNP A3 gene may
have arisen from the recombination of the 5 RNA recognition
motif-encoding segment of a former hnRNP A1 gene with the 3
Gly-rich segment of an earlier hnRNP A2 gene.
Protein Identification—Antibodies were raised against two
peptide sequences deduced from the FBRNP and hnRNP A3
gene sequences. The first peptide (VKPPPGRPQPDSGRR),
which was used in initial experiments (Fig. 1B), is in the
N-terminal alternatively spliced region. The second (GYDGY-
TABLE I
Protein sequences from Edman microsequencing
Tryptic peptides from the A2RE-binding proteins were isolated by
microbore reverse-phase HPLC and subjected to Edman degradation.
Protein Observed sequencesa
38 kDa EDSVK PGAHL TVK GGSFG GR
39 kDa EDSVK PGAHL TVK
41.5 kDa EDSVK PGAHL TV
hnRNP A1b EDSQR PGAHL TVK GGNFG GR
hnRNP A2b EESGK PGAHV TVK GGNFG GR
a At the underlined positions the low signal levels for the 41.5-kDa
band resulted in ambiguity in the identification of the residue. Ser and
Met were observed in the first position and Gly and Lys in the second.
These ambiguities do not interfere with the exclusion of hnRNPs A1
and A2. The residues in hnRNPs A1 and A2 that differ from those
observed are in bold type.
b EMBL accession numbers G296650 (hnRNP A1) and G500638
(hnRNP A2).
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NEGGNF) is in a segment of the glycine-rich region predicted
to be common to all splice variants of A3 but not fully conserved
in hnRNPs A1 and A2/B1. In Western blots the first antibody
recognized just the 41- and 41.5-kDa bands, suggesting that
only these proteins contain the 22-residue segment encoded
within exon 1 (Fig. 3). By contrast, the second antibody asso-
ciated with all four 38-, 39-, 41-, and 41.5-kDa bands, identify-
ing them as hnRNP A3-like proteins and not isoforms of
hnRNPs A1 or A2.
This identification was confirmed by Edman sequencing and
electrospray mass spectrometry. Bands cut from stained SDS/
polyacrylamide gels were pulverized and digested with trypsin,
and the reverse-phase HPLC-purified peptides were subjected
to Edman degradation. The resultant amino acid sequences,
presented in Table I, confirmed the identification of three of
these proteins as hnRNP A3. Each of the tryptic digests of the
excised bands was also subjected to liquid chromatography-
mass spectrometry (LC-MS), and the resultant peptide masses
were compared with those predicted from the putative protein
sequences. For each band, fragments spanning 33% or more of
the translated cDNA sequence matched the predicted masses of
tryptic fragments of hnRNP A3 (Table II). Where the putative
protein sequences differed, the observed masses corresponded
to the expected sequence and excluded the alternative FBRNP
protein, with the exception of one peptide, which gave a weak
signal at a mass corresponding to a peptide predicted for this
protein. The two protein sequences differ substantially in the
predicted tryptic fragments, and the absence of FBRNP pep-
tides in the mass spectral fingerprinting therefore indicates
that this protein is not expressed at levels comparable with
hnRNP A3. Thus, all four bands appear to be alternatively
spliced forms of hnRNP A3, with two of the forms lacking the
majority of exon 1. Alternatively spliced forms of both hnRNPs
A1 and A2 are expressed, with the inclusion or exclusion of
exon 7bis, resulting in hnRNPs A1 and A1B (40) and the alter-
native splicing of exons 2 and 9 giving rise to A2, B1, B0a, and
B0b (41, 42). By analogy we anticipated that the four forms of
A3 would arise from inclusion or exclusion of two alternatively
spliced exons.
To test this hypothesis, A2RE-binding proteins were isolated
using magnetic particle pull-down experiments and subjected
to LC-MS. Previous reverse-phase HPLC experiments2 had
shown that the hnRNP A3 isoforms co-elute ahead of hnRNP
A2. The LC-MS chromatogram gave a similar profile, but only
two proteins were detected in the hnRNP A3 peak, with aver-
age masses of 39,863  4 and 37,297  4 Da (Fig. 4); these
values are both 211 Da greater than the masses calculated
from the protein primary structures predicted from the DNA
sequences, indicating that the proteins have undergone post-
translational modification. The difference in mass between
these two isoforms, 2566 Da, corresponds to the mass of the
segment encoded by the N-terminal insertion (2567 Da), rein-
forcing the evidence for expression of these two forms and
identifying them as the nominally 38- and 41-kDa isoforms
(Fig. 1 and below). The 39- and 41.5-kDa isoforms were not
observed in the mass spectra, and the relationship between
them and the other two isoforms is not known. Although not
detected in the mass fingerprinting experiments, hnRNPs B1
and A1B, which migrate close to the hnRNP A3 bands on
SDS/polyacrylamide gel electrophoresis, did bind the A2RE
(Fig. 1B), as did the faster migrating hnRNP A1.
hnRNP A3 Interacts with the A2RE Independently of hnRNP
A2—Pull-down experiments with A2RE immobilized on mag-
netic particles have consistently yielded hnRNP A2 and the
less abundant hnRNP A3s. Given previous demonstrations
that purified A2 binds the A2RE, it was possible that hnRNP
A3 was isolated because it interacted with hnRNP A2 rather
than through a direct interaction with the oligoribonucleotide,
as suggested earlier (25). We therefore used the expressed
hnRNP A3 in UV cross-linking electrophoretic mobility shift
assays and biosensor experiments. Full-length rat hnRNP A3
(Fig. 2) was expressed in E. coli as a hexahistidine-tagged
protein and purified (Fig. 5A). Thrombin cleavage yielded
hnRNP A3 with two additional N-terminal residues, Gly-Ser,
arising from the thrombin cleavage site (calculated mass,
39,796 Da; measured average mass, 39,793  4 Da). Cleavage
of the fusion protein tag was accompanied by cleavage at a
2 T. Munro and R. Smith, unpublished results.
TABLE II
The 38-, 39-, 41-, and 41.5-kDa A2RE-binding proteins are all isoforms of hnRNP A3
Tryptic peptides from each of the SDS/polyacrylamide gel bands were separated by HPLC, and the masses measured by ion spray mass
spectrometry. The matching peptides from the 38- and 39-kDa bands cover 38% of truncated hnRNP A3 sequence, and those from the 41- and
41.5-kDa bands cover 33% of hnRNP A3. The predicted masses are monoisotopic and are calculated as [M].
Predicted
mass
38 39 41 41.5
Measured
mass
Residues in
truncA3
Measured
mass
Residues in
truncA3
Measured
mass
Residues in
full A3
Measured
mass
Residues in
full A3
570.34 570.41 82–86 570.43 82–86 570.41 104–108 570.42 104–108
700.31 700.32 122–126 700.33 122–126 700.35 144–148 700.35 144–148
997.56 997.46 78–86 997.44 78–86 997.48 100–108 997.49 100–108
1048.49 1048.42 122–129 1048.41 122–129 1048.44 144–151 1048.44 144–151
1120.49 1120.48 183–192a 1120.49 183–192a 1120.49 205–214a 1120.51 205–214a
1167.50 1167.55 113–121 1167.63 113–121 1167.63 135–143 1167.63 135–143
1233.59 1233.52 130–139 1233.69 130–139 1233.68 152–161 1233.67 152–161
1379.74 1379.80 92–104 1379.77 92–104 1379.82 114–126 1379.82 114–126
1581.77 1581.79 127–139 1581.85 127–139
1712.77 1712.78 146–160a 1712.78 146–160a 1712.88 168–182a 1712.77 168–182a
1775.86 1775.90 21–35a,b 1775.90 21–35a,b
1769.88 1769.86 15–30 1769.90 15–30 1769.92 37–52 1769.92 37–52
1797.80 1797.92 205–224a 1797.89 205–224a
1868.87 1868.88 145–160a 1868.90 145–160a 1868.94 167–182a
1881.95 1881.95 106–121a 1881.95 106–121a 1881.98 128–143a 1881.97 128–143a
1897.98 1898.00 14–30 1898.00 14–30
1909.78 1909.81 334–355c 1909.81 334–355c 1909.84 356–377c 1909.78 356–377c
2010.04 2010.04 105–121a 2010.07 105–121a 2010.10 127–143a
a Peptides that are only found in rat hnRNP A3 and not in the protein encoded by the putative pseudogene.
b Peptide found in full-length hnRNP A3 but not the truncated isoform.
c Identity confirmed by MS/MS.
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second site, marked with an arrow above the amino acid se-
quence in Fig. 2, that removed 24 residues from the C-terminal
end of the molecule (calculated mass, 37,600 Da; measured
average mass, 37,597  4 Da). The full-length cleaved recom-
binant hnRNP A3 co-migrated with the 41-kDa band when run
alongside the A2RE-binding rat brain proteins on an SDS/
FIG. 4. Mass spectrometry identi-
fies two hnRNP A3 isoforms. Rat brain
A2RE-binding proteins were isolated us-
ing A2RE immobilized on magnetic parti-
cles. The proteins were eluted from the
particles in 30% acetonitrile in 0.1% trif-
luoroacetic acid, concentrated by vacuum
centrifugation, centrifuged to remove any
particulate material, and analyzed by
C18 reverse-phase liquid chromatogra-
phy-orthogonal quadrupole/time-of-flight
mass spectrometry. In the total ion cur-
rent chromatogram the peaks labeled A,
B, and C yielded mass spectra of hnRNP
A2 (36,076), the hnRNP A3 isoform miss-
ing part of exon 1 (37,297), and the
hnRNP A3 isoform possessing the full
exon 1 (39,863), respectively. The other
peaks in the chromatogram are derived
from smaller proteins that are bound non-
specifically to the magnetic particles. Ex-
pansion of the mass spectra for peaks A–C
revealed small amounts of sodium adduct
but no other components.
FIG. 5. Purification of bacterially expressed hnRNP A3. A, Coomassie Blue-stained SDS/polyacrylamide gel showing the purification of the
bacterially expressed hnRNP A3 (rA3). The tracks show uninduced bacterial lysate (Control), the lysate from cells induced with isopropyl-1-thio-
-D-galactopyranoside (rA3), rA3 purified on a chelated metal column (IMAC), rA3 after further purification by reverse-phase HPLC (HPLC), and
rA3 after complete thrombin cleavage of the hexahistidine tag (cleaved). Thrombin cleaved at three sites: those anticipated within the tag and
between the hexahistidine tag and the hnRNP A3 coding region and an unexpected site 24 residues from the C-terminal end, yielding a product
with a molecular mass of 37,597 Da (shown). The positions of the cleavage sites were deduced from electrospray/time-of-flight mass measurements.
The positions of marker proteins are shown at left. B, in Western blots the full-length recombinant protein migrated close to the rat 41-kDa
A2RE-binding protein. The tracks show proteins bound to nonspecific oligonucleotide (NS) and detected with the Gly-rich region hnRNP A3 peptide
antibody (A3(C)), rat brain A2RE-binding proteins (A2RE) detected with A3(C) and N-terminal peptide (A3(N)) antibodies, respectively, and partly
digested recombinant hnRNP A3 detected with A3(N), showing the full-length protein (arrow) migrating with the rat brain 41-kDa isoform, behind
the C-terminally truncated hnRNP A3 (arrowhead).
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polyacrylamide gel (Fig. 5B), suggesting that this rat protein
corresponds in sequence to the expressed protein. This conclu-
sion is consistent with the Western blots (Fig. 3) showing that
the 41- and 41.5-kDa proteins contain the N-terminal insertion
shown in Fig. 2.
Biosensor measurements in which A2RE or nonspecific oli-
goribonucleotide (NS1) was added to purified, expressed His-
tagged hnRNP A3 immobilized on the cuvette showed that the
oligonucleotide binding to this protein closely parallels the
binding to hnRNP A2 (43). A saturating concentration of NS1
(30 M) or A2RE (4 M) was added to the biosensor, resulting in
a response with A2RE double that with NS1. After attainment
of equilibrium (Fig. 6A, arrow), sufficient A2RE was added to
each biosensor to double its concentration. This addition led to
little change in the response upon addition to A2RE but to a
doubling of the biosensor response upon addition of A2RE to
the cuvette previously containing only NS1 (Fig. 6A, top panel).
By contrast, doubling of the concentration of NS1 in the cuvette
previously equilibrated with this oligoribonucleotide did not
further increase the biosensor response (Fig. 6A, bottom panel).
The parallel between the oligoribonucleotide binding to
hnRNPs A3 and A2 indicated that the former also possesses
one site that binds RNA sequence specifically and a second site
that manifests no strong sequence specificity. Additional sup-
port for this proposition was obtained from studies of the effect
of 10 g/liter heparin. This polyanion halved the binding of
A2RE to hnRNP A3 (Fig. 6B, top panel) and eliminated NS1
binding (Fig. 6B, bottom panel). The affinity of recombinant
hnRNP A3 for both NS1 and A2RE, as reflected in the dissoci-
ation constants derived from the binding curves (Fig. 6C), is
lower than for human recombinant hnRNP A2. The Kd for the
specific site is 276 35 nM compared with 44 7 nM for hnRNP
A2, and the corresponding values for the nonspecific site are
3.0  0.6 M (A2RE) and 4.8  0.6 M (NS1) for hnRNP A3
compared with 267 41 nM (A2RE) and 246 29 nM (dNS1) for
hnRNP A2. UV cross-linking electrophoretic mobility shift ex-
periments showed binding of radiolabeled A2RE to hnRNPs A2
and A3 and lower binding of NS1, in accord with the biosensor
experiments (Fig. 7A). Competition assays confirmed the spec-
ificity of the RNA-protein interaction (Fig. 7B).
Earlier experiments had shown a correlation between
hnRNP A2 binding to A2RE and corresponding oligonucleo-
tides with point mutations and the ability of these sequences to
support transport of RNAs (26). Together with antisense oligo-
nucleotide data, these observations suggested a role for hnRNP
A2 in cytoplasmic mRNA trafficking. Because the binding to
A2RE of hnRNP A3 correlated closely with that of A2 in these
earlier experiments, it appears that the former proteins may
also play some part in RNA trafficking, but confirmation of this
proposal requires a more direct experimental demonstration.
hnRNP A3 Distribution in Rat Tissues Mirrors hnRNP A2—
The distribution of hnRNP A3 has not previously been inves-
tigated. Equal amounts of protein extracted from rat tissues
were separated on multiple lanes of an SDS/polyacrylamide gel
and electroblotted onto nitrocellulose for detection with anti-
peptide antibodies to hnRNPs A2 and the N-terminal peptide of
A3. hnRNP A3 was found in several tissues, most prominently
in brain, lung, and testis, and its levels in these tissues paral-
leled those of hnRNP A2 (Fig. 8). Little or no hnRNP A2 or A3
was detected in muscle, kidney, heart, or liver. Lower molecu-
lar mass forms of both proteins were reproducibly observed in
extracts of spleen.
hnRNP A3 Is Co-localized with A2RE-containing RNA in the
Cytoplasm of Neurons—If hnRNP A3 is involved in cytoplasmic
RNA trafficking, it might be expected to be localized in cyto-
plasmic granules and to be co-localized with A2RE-containing
RNA. Immunofluorescence microscopy showed hnRNP A3 to be
present in the nucleus (not shown) and in cytoplasmic granules
in the neurites of cultured hippocampal neurons (Fig. 9A), with
hnRNPs A2 and A3 being localized to different populations of
granules (Fig. 9). Microinjected fluorescently labeled A2RE-
containing RNA was also co-localized with hnRNP A3 in a
subset of cytoplasmic granules (Fig. 10). These results, to-
gether with earlier data (26) showing that mutations in the
FIG. 6. hnRNP A3 binds A2RE. Biosensor assays show sequence-specific and nonspecific binding of oligoribonucleotides to immobilized hnRNP
A3. A, saturating concentrations of A2RE or NS1 were added to the cuvette at time 0. After attainment of binding equilibrium, A2RE sufficient
to increase its concentration by 4 M was added to each cuvette (arrow). Only the hnRNP A2 previously equilibrated with NS1 showed increased
binding upon addition of the second aliquot of oligonucleotide (top panel), suggesting that the protein possesses a site that binds A2RE but not
equivalent oligonucleotides with scrambled sequences. In a parallel experiment, 30 M NS1, rather than A2RE, was added after the attainment
of equilibrium (bottom panel). The addition of further NS1, in contrast to A2RE, results in only a minor increase in binding. B, comparison of the
biosensor response for the binding of a saturating concentration of A2RE (4 M) to immobilized hnRNP A3 (top panel) with that for an
oligoribonucleotide with the same composition but scrambled sequence (NS1; 30 M; bottom panel). The response with A2RE is twice that with NS1.
Heparin (1.0 g/liter) halves the A2RE response (top panel) and eliminates the response for NS1 (bottom panel). C, concentration dependence of
A2RE and NS1 binding to hnRNP A3. The Kd values were derived from these curves.
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A2RE that lower binding to hnRNP A2 and A3 interfere with
RNA trafficking,3 suggest that hnRNPs A2 and A3 both play a
role in RNA trafficking in neurites.
DISCUSSION
The four most abundant of the A2RE-binding rat brain pro-
teins migrating behind hnRNP A2 on SDS/polyacrylamide gels
have been identified by mass fingerprinting and Edman se-
quencing of tryptic peptides as hnRNP A3 isoforms (Tables I
and II). These peptides had sequences consistent with our
hnRNP A3 cDNA sequences and excluded the possibility that
any of the four proteins were splice variants of hnRNPs A1 or
A2. This conclusion was also consistent with the results of
Western blotting using two antibodies raised against peptides
from hnRNP A3 (Fig. 3).
In the course of identifying these proteins, we completed the
3 J. Shan, T. P. Munro, E. Barbarese, J. H. Carson, and R. Smith,
unpublished results.
FIG. 7. Electrophoretic mobility
shift assays. A, UV cross-linking electro-
phoretic mobility shift experiments show-
ing binding of recombinant hnRNPs A2
and histidine-tagged hnRNP A3 to radio-
labeled A2RE11 and an oligonucleotide
comprising the 11 5 nucleotides of NS1.
The positions of marker proteins, with
molecular masses in kDa, are shown on
the left. B, a 50-fold excess of unlabeled
A2RE11 but not of NS1 11-mer competed
for the A2RE binding site on detagged
recombinant hnRNP A3. A 50-fold excess
of either A2RE11 or NS1 11-mer elimi-
nated binding of NS1 to hnRNP A3.
FIG. 8. hnRNP A3 expression parallels hnRNP A2 expression in several rat tissues. Proteins were extracted from 21-day-old Wistar rat
tissues, separated on SDS/polyacrylamide gels, and electroblotted onto nitrocellulose. The blots were developed using antibodies against whole
hnRNP A2 (left panel) and the N-terminal hnRNP A3 peptide (which recognizes the 41- and 41.5-kDa isoforms) (right panel). The bands were
visualized using rabbit IgG alkaline phosphatase-conjugated secondary antibody. The distribution of both proteins in these tissues is highly
correlated. The positions of molecular mass markers, with masses in kDa, are indicated on the left.
FIG. 9. hnRNP A3 is present in cyto-
plasmic granules. A, confocal laser
scanning microscopy image of the neu-
rites of a cultured hippocampal neuron
using a mouse antibody to hnRNP A2 and
a rabbit antibody to an N-terminal pep-
tide unique to hnRNP A3. Both hnRNP
A2 (green, arrows) and hnRNP A3 (red,
arrowheads) were detected in granules,
which had the appearance and distribu-
tion of transport granules, in the neurites.
Scale bar, 5 m. B, statistical analysis of
the fluorescence of individual granules
showed that the majority of granules in
the neurites contained either hnRNP A2
or hnRNP A3. A small number of granules
were yellow, indicating the presence of
both proteins.
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sequences of human and rat hnRNP A3 cDNAs. The hnRNP A3
amino acid sequence is highly conserved between humans and
rats, as are those of hnRNPs A1 and A2. Initially two human
cDNAs were amplified; both appeared to encode full-length
hnRNP A/B-like proteins, one corresponding in protein se-
quence with the previously described FBRNP expressed se-
quence tag, and the other corresponding with the reported
hnRNP A3 partial sequence (28). However, the FBRNP se-
quence appears to arise from a processed pseudogene; although
it is transcribed and has appropriately located start and stop
codons and polyadenylation signal, it corresponds to a gene on
human chromosome 10 that possesses a single exon, in contrast
to the 10–12 exons of other human and mouse hnRNP A/B
genes (41, 44). Although an intronless paralog has been discov-
ered for hnRNP E (45), the potential protein product of FBRNP
DNA, which has a predicted mass close to one of the hnRNP A3
isoforms, was not detected in mass spectrometric fingerprint-
ing of peptides derived from any of the four hnRNP A3 bands,
indicating either that it is not translated in amounts compara-
ble with the other hnRNP A3 isoforms or that the resultant
protein does not bind the A2RE. A search of the DNA data
bases revealed several other hnRNP A3 pseudogenes on differ-
ent human chromosomes.
Both hnRNPs A2 and A3 are expressed as four isoforms. The
hnRNP A2 isoforms arise from exclusion or inclusion of exons 2
(36 nucleotides) and 9 (120 nucleotides), generating B0a, B0b
( exon 2), A2 ( exon 9), and B1 ( exons 2 and 9) (44, 46).
The two higher molecular mass forms isoforms (41 and 41.5
kDa) of hnRNP A3, but not the two lower molecular mass forms
(38 and 39 kDa) contain an N-terminal 22-amino acid insertion
(Fig. 2), which was discovered using 5-RACE; only the two
higher molecular mass proteins bound antibodies raised
against a peptide within this N-terminal insertion. Within
these two doublets the apparent mass difference is 1–1.5 kDa,
corresponding to 10–15 amino acid residues, but RT-PCR did
not reveal any mRNAs varying by this size and in attempts to
determine the masses of all four isoforms by LC-MS only two
proteins with masses in the appropriate range were detected.
Their masses and the co-migration on SDS/polyacrylamide gels
of the recombinant hnRNP A3 with the 41-kDa isoform (Fig. 4)
suggest that the two observed masses, 37,297 and 39,863 Da,
are those of the nominally 38- and 41-kDa isoforms. Several
potential reasons for the nonappearance of the 39- and 41.5-
kDa isoforms in mass spectrometry experiments have been
eliminated; every chromatographic peak from the LC-MS runs
was analyzed, but none contained proteins in the 37–45-kDa
mass range, other than the two mentioned above. All four
isoforms were present in the sample used for mass spectrome-
try, and all usually elute with similar retention times on re-
verse-phase HPLC, as shown by SDS/polyacrylamide gel
electrophoresis.
We had previously discovered, from mutational analysis and
antisense oligonucleotide experiments, that hnRNP A2 is a
trans-acting factor for A2RE-mediated, cytoplasmic RNA traf-
ficking in oligodendrocytes (26) and neurons.3 In these experi-
ments it was noted that the hnRNP A3 isoforms were also
FIG. 10. Microinjected A2RE RNA
and hnRNP A3 are co-localized in
neuronal neurites. A, hippocampal neu-
rons were microinjected with fluores-
cently labeled A2RE RNA. The subcellu-
lar distributions of the injected RNA (left
panels) and hnRNP A3 (right panels)
were visualized and analyzed by dual
channel confocal microscopy, using rabbit
primary antibody and Alexa 598-labeled
secondary antibody to locate hnRNP A3
after fixing the cells. In each image, the
arrows indicate granules that contain
both A2RE RNA and hnRNP A3, and the
arrowheads indicate granules with only
hnRNP A3 labeling. Granules positive for
hnRNP A3 but negative for injected RNA
may transport endogenous A2RE-con-
taining RNA. Scale bars, 5 m. B, analy-
sis of hnRNP A3 and A2RE-containing
RNA distributions in individual granules,
showing a linear correlation between the
levels of the two proteins and a popula-
tion of granules that contain hnRNP A3
but low levels of exogenous RNA. RNA
lacking the A2RE is not transported into
the processes of oligodendrocytes (26) or
neurons.3
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isolated from rat brain protein extracts in pull-down experi-
ments with immobilized A2RE and that their binding to mu-
tated forms of the A2RE paralleled that of hnRNP A2. This left
open the possibility that hnRNP A3 bound directly to A2RE or
indirectly through association with hnRNP A2. The biosensor
and gel mobility shift data presented here support the former
interpretation. The biosensor responses with purified recombi-
nant hnRNP A3 (Fig. 6) closely paralleled those recorded for
hnRNP A2 (43), indicating that hnRNP A3, like hnRNP A2,
possesses two RNA-binding sites; one of them is sequence-
specific, binding to A2RE, and the other binds with little dis-
crimination between sequences. Although the RNA recognition
motifs of hnRNP A3 are closer in sequence to hnRNP A1 than
to hnRNP A2, hnRNP A3 mimics hnRNP A2 more closely than
hnRNP A1 in its binding to A2RE, although with dissociation
constants for A2RE binding that are severalfold higher than for
hnRNP A2.
Although hnRNP A3 was not described originally as a com-
ponent of the core particles identified in HeLa cell nuclei, it is
present in multiple isoforms in these cells (47). We have shown
that hnRNP A3 is abundant in several tissues, paralleling the
tissue distribution of hnRNP A2. hnRNP A3, like hnRNP A2, is
mostly localized in the nuclei of neurons and oligodendrocytes
(not shown) and probably has a similar localization in other cell
types.
Association of hnRNP A3 with A2RE in vivo is suggested by
two of our observations. First, in neurons this protein is
localized to granules in neurites that are similar in size and
number to those shown previously to participate in traffick-
ing of A2RE-containing RNA.3 Interestingly, most granules
in the neurites were positive for either hnRNP A2 or hnRNP
A3, but not both. It has been shown that inclusion in trans-
port granules requires a cooperative interaction between
hnRNP A2 and RNA and that there are multiple copies of
A2RE-containing RNA and probably multiple copies of
hnRNP A2 in each granule.4 Our observation that few cyto-
plasmic granules contain both hnRNPs A2 and A3 thus indi-
cates that these two proteins do not interact cooperatively
with each other in recruiting RNA to the transport granules.
The second observation that implicates hnRNP A3 in the
cytoplasmic trafficking of RNA is the co-localization of micro-
injected A2RE RNA with hnRNP A3 in granules that are
distributed along the neurites.
The parallels in A2RE binding, tissue, and subcellular
distribution of hnRNPs A2 and A3 beg the question of
whether these proteins fulfill the same or similar roles in vivo
in A2RE-dependent RNA trafficking. hnRNP A2 has been
shown to be involved in cytoplasmic trafficking (25, 26) and in
the regulation of translation (27), and hnRNP A3 could also
be involved in these aspects of RNA metabolism or in others
such as nuclear export, RNA tethering at its destination, or
mRNA stability. It will be of particular interest to explore the
differences in role between the isoforms of each protein. The
observation that hnRNP B1 expression is selectively up-
regulated in oncogenically transformed cells (48, 49) is an
indication that regulation of splicing of RNA encoding
hnRNPs and hence of protein isoform expression may play an
important role in cell biology.
In summary, we have shown that the predominant rat brain
A2RE-binding proteins are hnRNP A2 and four isoforms of
hnRNP A3. Bacterially expressed hnRNP A3 has been found in
biosensor and gel mobility shift assays to bind A2RE, showing
that this protein can bind A2RE directly and does not neces-
sarily associate with A2RE indirectly by binding to an RNA-
hnRNP A2 complex. A role for hnRNP A3 in cytoplasmic RNA
trafficking, which may parallel that of hnRNP A2, is suggested
by its co-localization with hnRNP A2 in tissues and its subcel-
lular co-localization with A2RE RNA in neuronal transport
granules. The sequestration of these hnRNPs into two separate
populations of granules in the neuronal neurites raises inter-
esting questions about the mechanism by which they are re-
cruited to the transport granules.
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